酸通过改善肠道屏障功能来抑制引起的结肠损伤
Shumin Wang1, Yan Hong1, Yuxiu Li1
1Department of Histology and Embryology, School of Basic Medicine, Guizhou Medical University, Guiyang, Guizhou, People's Republic of China.
Environmental toxicology
|June 17, 2024
概括
酸 (FA) 通过减少氧化应激和炎症来保护免受引起的肠损伤. FA 维护了肠道屏障的完整性,可能是暴露引起的结肠损伤的潜在治疗方法.
科学领域:
- 毒理学 毒理学 毒理学
- 胃肠病学 胃肠病学
- 生物化学 生化学
背景情况:
- 暴露会导致肠道屏障功能障碍,氧化应激和炎症.
- 酸 (FA) 具有抗氧化和抗炎性质,可以减轻引起的其他器官损伤.
- 对于FA保护肠道免受毒性的潜力还没有被探索.
研究的目的:
- 研究ferulic acid (FA) 对引起的肠损伤的保护作用.
- 阐明涉及紧结蛋白,氧化应激和关键信号通路的潜在机制.
主要方法:
- 暴露于甲的小鼠接受了FA治疗,评估了结肠组织病理和紧结 (TJ) 蛋白质水平.
- 暴露于甲的Caco-2细胞被FA处理以评估氧化应激和TJ蛋白表达.
- 在结肠和Caco-2细胞中对NF-κB和Nrf2/HO-1通路进行了分子分析.
主要成果:
- 治疗FA改善了结肠粘膜的完整性,并逆转了引起的TJ蛋白的下调 (Claudin-1,Occludin,ZO-1).
- FA抑制了氧化应激和减弱了对Caco-2细胞TJ蛋白表达的抑制作用.
- 在暴露于的结肠和肠细胞中,FA抑制了NF-κB的激活,并恢复了Nrf2/HO-1通路的激活.
结论:
- 酸通过保持肠道上皮质紧密结合的完整性来减轻引起的肠损伤.
- 通过抑制氧化应激和调节NF-κB和Nrf2/HO-1通路,FA具有保护作用.
- 这些发现支持FA在引起的结肠损伤中的潜在治疗应用.
相关概念视频
Drugs for Treatment of Ulcerative Colitis in IBD
135
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
135
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
440
In the intricate landscape of the gastric lumen, excessive acid secretion disrupts the natural defense mechanisms, weakening the mucus-bicarbonate barrier. This vulnerability allows pepsin to infiltrate epithelial cells, digesting mucosal proteins and triggering erosion, leading to ulcer formation.
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
440
Inflammatory Bowel Disease I: Ulcerative Colitis
161
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
161


